210 related articles for article (PubMed ID: 29288894)
1. Delivery of [Ru(η
Edeler D; Arlt S; Petković V; Ludwig G; Drača D; Maksimović-Ivanić D; Mijatović S; Kaluđerović GN
J Inorg Biochem; 2018 Mar; 180():155-162. PubMed ID: 29288894
[TBL] [Abstract][Full Text] [Related]
2. Antitumor potential of cisplatin loaded into SBA-15 mesoporous silica nanoparticles against B16F1 melanoma cells: in vitro and in vivo studies.
Drača D; Edeler D; Saoud M; Dojčinović B; Dunđerović D; Đmura G; Maksimović-Ivanić D; Mijatović S; Kaluđerović GN
J Inorg Biochem; 2021 Apr; 217():111383. PubMed ID: 33582397
[TBL] [Abstract][Full Text] [Related]
3. Impact of the mesoporous silica SBA-15 functionalization on the mode of action of Ph
Edeler D; Drača D; Petković V; Natalio F; Maksimović-Ivanić D; Mijatović S; Schmidt H; Kaluđerović GN
Mater Sci Eng C Mater Biol Appl; 2019 Jul; 100():315-322. PubMed ID: 30948067
[TBL] [Abstract][Full Text] [Related]
4. Arene Ruthenium(II) Complexes Bearing the κ-
Arlt S; Petković V; Ludwig G; Eichhorn T; Lang H; Rüffer T; Mijatović S; Maksimović-Ivanić D; Kaluđerović GN
Molecules; 2021 Mar; 26(7):. PubMed ID: 33806101
[TBL] [Abstract][Full Text] [Related]
5. Ketoprofen mesoporous silica nanoparticles SBA-15 hard gelatin capsules: preparation and in vitro/in vivo characterization.
Abd-Elrahman AA; El Nabarawi MA; Hassan DH; Taha AA
Drug Deliv; 2016 Nov; 23(9):3387-3398. PubMed ID: 27167529
[TBL] [Abstract][Full Text] [Related]
6. Preparation of efficient quercetin delivery system on Zn-modified mesoporous SBA-15 silica carrier.
Trendafilova I; Szegedi A; Mihály J; Momekov G; Lihareva N; Popova M
Mater Sci Eng C Mater Biol Appl; 2017 Apr; 73():285-292. PubMed ID: 28183610
[TBL] [Abstract][Full Text] [Related]
7. Modulation of the mechanism of apoptosis in cancer cell lines by treatment with silica-based nanostructured materials functionalized with different metallodrugs.
Díaz-García D; Cenariu D; Pérez Y; Cruz P; Del Hierro I; Prashar S; Fischer-Fodor E; Gómez-Ruiz S
Dalton Trans; 2018 Sep; 47(35):12284-12299. PubMed ID: 30112529
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of functionalized mesoporous silica SBA-15 as a carrier system for Ph
Bensing C; Mojić M; Gómez-Ruiz S; Carralero S; Dojčinović B; Maksimović-Ivanić D; Mijatović S; Kaluđerović GN
Dalton Trans; 2016 Dec; 45(47):18984-18993. PubMed ID: 27847952
[TBL] [Abstract][Full Text] [Related]
9. Inorganic mesoporous silicas as vehicles of two novel anthracene-based ruthenium metalloarenes.
Rojas S; Carmona FJ; Barea E; Maldonado CR
J Inorg Biochem; 2017 Jan; 166():87-93. PubMed ID: 27838582
[TBL] [Abstract][Full Text] [Related]
10. A new generation of anticancer drugs: mesoporous materials modified with titanocene complexes.
Pérez-Quintanilla D; Gómez-Ruiz S; Zizak Z; Sierra I; Prashar S; del Hierro I; Fajardo M; Juranić ZD; Kaluderović GN
Chemistry; 2009; 15(22):5588-97. PubMed ID: 19370742
[TBL] [Abstract][Full Text] [Related]
11. Luminescence functionalization of SBA-15 by YVO4:Eu3+ as a novel drug delivery system.
Yang P; Huang S; Kong D; Lin J; Fu H
Inorg Chem; 2007 Apr; 46(8):3203-11. PubMed ID: 17371013
[TBL] [Abstract][Full Text] [Related]
12. Modified SBA-15 mesoporous silica for heavy metal ions remediation.
Mureseanu M; Reiss A; Stefanescu I; David E; Parvulescu V; Renard G; Hulea V
Chemosphere; 2008 Nov; 73(9):1499-504. PubMed ID: 18760443
[TBL] [Abstract][Full Text] [Related]
13. Effect of chain length on the cytotoxic activity of (alkyl-ω-ol)triphenyltin(IV) loaded into SBA-15 nanostructured silica and in vivo study of SBA-15~Cl|Ph
Bensing C; Mojić M; Bulatović M; Edeler D; Pérez-Quintanilla D; Gómez-Ruiz S; Maksimović-Ivanić D; Mijatović S; Kaluđerović GN
Biomater Adv; 2022 Sep; 140():213054. PubMed ID: 35964389
[TBL] [Abstract][Full Text] [Related]
14. Adsorption of lysozyme on hyaluronic acid functionalized SBA-15 mesoporous silica: a possible bioadhesive depot system.
Medda L; Casula MF; Monduzzi M; Salis A
Langmuir; 2014 Nov; 30(43):12996-3004. PubMed ID: 25295387
[TBL] [Abstract][Full Text] [Related]
15. Picolinate ruthenium(II)-arene complex with in vitro antiproliferative and antimetastatic properties: comparison to a series of ruthenium(II)-arene complexes with similar structure.
Gligorijević N; Aranđelović S; Filipović L; Jakovljević K; Janković R; Grgurić-Šipka S; Ivanović I; Radulović S; Tešić ZLj
J Inorg Biochem; 2012 Mar; 108():53-61. PubMed ID: 22266461
[TBL] [Abstract][Full Text] [Related]
16. Carboxylic modified spherical mesoporous silicas аs drug delivery carriers.
Popova MD; Szegedi Á; Kolev IN; Mihály J; Tzankov BS; Momekov GT; Lambov NG; Yoncheva KP
Int J Pharm; 2012 Oct; 436(1-2):778-85. PubMed ID: 22884833
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of Ru(III) complexes carrying beta-diketonato ligands in vitro and in vivo.
Arandjelovic SS; Bjelogrlic KS; Malesevic NN; Tesic LjZ; Radulovic SS
J BUON; 2009; 14(2):271-9. PubMed ID: 19650178
[TBL] [Abstract][Full Text] [Related]
18. Direct surface grafting of mesoporous silica nanoparticles with phospholipid choline-containing copolymers through chain transfer free radical polymerization and their controlled drug delivery.
Huang L; Wu J; Liu M; Mao L; Huang H; Wan Q; Dai Y; Wen Y; Zhang X; Wei Y
J Colloid Interface Sci; 2017 Dec; 508():396-404. PubMed ID: 28843929
[TBL] [Abstract][Full Text] [Related]
19. Tuning the cytotoxicity of ruthenium(ii) para-cymene complexes by mono-substitution at a triphenylphosphine/phenoxydiphenylphosphine ligand.
Biancalana L; Zacchini S; Ferri N; Lupo MG; Pampaloni G; Marchetti F
Dalton Trans; 2017 Dec; 46(47):16589-16604. PubMed ID: 29164209
[TBL] [Abstract][Full Text] [Related]
20. The properties of mesoporous silica nanoparticles functionalized with different PEG-chain length via the disulfide bond linker and drug release in glutathione medium.
Xie Z; Gong H; Liu M; Zhu H; Sun H
J Biomater Sci Polym Ed; 2016; 27(1):55-68. PubMed ID: 26540096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
